The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)



Status:Completed
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:12 - 50
Updated:4/21/2016
Start Date:June 2007
End Date:January 2010

Use our guide to learn which trials are right for you!

The Impact of Docosahexaenoic Acid on Neuropsychological Status in Females With Phenylketonuria

The purpose of this study is to determine if taking supplemental DHA improves measures of
processing speed and executive function in teen and adult women with PKU.


Inclusion Criteria:

- Females

- Phenylketonuria

- Ages 12 years and older

- Able to complete neuropsychological testing

Exclusion Criteria:

- Pregnancy

- Currently taking DHA supplement
We found this trial at
1
site
201 Dowman Dr
Atlanta, Georgia 30303
(404) 727-6123
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials